Impact of timing on mucosal healing during restaging endoscopy in pediatric Crohn's disease: A retrospective cohort study
Open Access
- 12 November 2025
- journal article
- Published by Wiley in JPGN Reports
- Vol. 7 (1) , 99-106
Abstract
While endoscopic remission is an important target in pediatric Crohn's disease (CD), no consensus for restaging timing exists. This retrospective cohort study assessed the timing and impact of restaging endoscopy in children with new CD in remission, comparing earlier ( ≤ 9 months) versus later endoscopy. Twenty‐five patients were included (median: 12.6 years, range: 5–17). Endoscopic remission (no ulcerations) was achieved in 72% ( n = 18/25). Thirteen patients (52%) had earlier endoscopy (median: 7 months, interquartile range [IQR]: 6–9, range: 3–9) while 12 (48%) had later (median: 14.5 months, IQR: 13–17, range: 11–20). There were no differences in endoscopic remission (earlier 77% vs. later 67%; p = 0.69) or therapy escalation after restaging (earlier 23% vs. later 42%; p = 0.44). This study demonstrates that one in four pediatric Crohn's disease patients in clinical and biochemical remission were not in endoscopic remission, regardless of the timing of restaging endoscopy. This indicates potential benefit to earlier restaging endoscopy in clinical decision‐making.Keywords
This publication has 24 references indexed in Scilit:
- Deep Remission at 1 Year Prevents Progression of Early Crohn’s DiseaseGastroenterology, 2020
- Clinical disease activity and endoscopic severity correlate poorly in children newly diagnosed with Crohn’s diseaseGastrointestinal Endoscopy, 2019
- Associations Among Mucosal and Transmural Healing and Fecal Level of Calprotectin in Children With Crohn’s DiseaseClinical Gastroenterology and Hepatology, 2018
- Treat to Target: A Proposed New Paradigm for the Management of Crohn's DiseaseClinical Gastroenterology and Hepatology, 2015
- Increased Effectiveness of Early Therapy With Anti-Tumor Necrosis Factor-α vs an Immunomodulator in Children With Crohn's DiseaseGastroenterology, 2014
- Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel diseaseInflammatory Bowel Diseases, 2012
- Mathematical weighting of the pediatric Crohnʼs disease activity index (PCDAI) and comparison with its other short versionsInflammatory Bowel Diseases, 2012
- Pediatric modification of the Montreal classification for inflammatory bowel diseaseInflammatory Bowel Diseases, 2011
- Mucosal Healing in Inflammatory Bowel Disease: Results From a Norwegian Population-Based CohortGastroenterology, 2007
- Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CDGastrointestinal Endoscopy, 2004